摘要
目的探析冠状动脉粥样硬化性心脏病(冠心病)患者实施经皮冠状动脉介入治疗的效果。方法68例冠心病患者,均进行经皮冠状动脉介入治疗。比较患者治疗前后不良情绪评分、心功能指标水平、炎症因子水平,统计其不良事件、死亡率以及术后半年心电图检测情况。结果治疗后,患者的焦虑评分(50.23±6.57)分、抑郁评分(49.20±2.08)分及白细胞介素-2(34.22±3.27)ng/L、C反应蛋白(16.71±2.51)mg/L均明显低于治疗前的(68.32±7.49)分、(68.33±4.82)分、(58.88±7.99)ng/L、(27.39±3.88)mg/L,左室射血分数(54.54±3.88)%高于治疗前的(48.11±2.79)%,左心室舒张末径(53.39±3.41)mm小于治疗前的(59.61±4.91)mm,差异具有统计学意义(P<0.05)。治疗后,患者的心理领域、独立性、环境、社会关系、生理评分分别为(25.32±3.38)、(27.33±2.32)、(23.33±3.96)、(24.32±4.22)、(10.34±2.75)分,均明显高于治疗前的(20.10±3.95)、(23.11±2.98)、(17.11±3.57)、(18.10±4.07)、(6.11±2.20)分,差异具有统计学意义(P<0.05)。治疗后,不良事件发生率为4.41%(3/68),死亡率为1.47%(1/68)。术后半年为患者进行心电图检测,结果显示,房性心动过速、心房颤动、频发房性期收缩、频发室性期前收缩例数分别为4例(5.88%)、3例(4.41%)、2例(2.94%)、1例(1.47%)。结论冠心病患者使用经皮冠状动脉介入治疗在临床疗效和预后恢复方面均具有良好表现,使患者不良情绪得到缓解,心功能指标得到改善,临床应用价值较高。
Objective To discuss and analyze the effect of percutaneous coronary intervention on the prognosis and recovery of patients with coronary atherosclerotic heart disease.Methods All 68 patients with coronary heart disease underwent percutaneous coronary intervention.The adverse mood scores,cardiac function index levels,and inflammatory factor levels were compared before and after treatment,and the adverse events,mortality,and electrocardiogram detection in half a year after surgery were counted.Results After treatment,the patient's anxiety score(50.23±6.57)points,depression score(49.20±2.08)points,interleukin-2(34.22±3.27)ng/L,C-reactive protein(16.71±2.51)mg/L were significantly Lower than(68.32±7.49)points,(68.33±4.82)points,(58.88±7.99)ng/L,(27.39±3.88)mg/L before treatment;the left ventricular ejection fraction(54.54±3.88)%was higher than(48.11±2.79)%before treatment;the left ventricular end-diastolic diameter(53.39±3.41)mm was smaller than(59.61±4.91)mm before treatment;all the differences were statistically significant(P<0.05).After treatment,the patient's psychological domain,independence,environment,social relationship,and physiological scores were(25.32±3.38),(27.33±2.32),(23.33±3.96),(24.32±4.22),and(10.34±2.75)points,which were significantly higher than(20.10±3.95),(23.11±2.98),(17.11±3.57),(18.10±4.07),and(6.11±2.20)points before treatment,and the differences were statistically significant(P<0.05).After treatment,the adverse event rate of 4.41%(3/68)and a mortality rate of 1.47%(1/68).Electrocardiographic tests were performed for the patients six months after surgery,and the results showed that the number of cases of atrial tachycardia,atrial fibrillation,frequent atrial phase contraction,and frequent ventricular phase contraction were 4 cases(5.88%),3 cases(4.41%),2 cases(2.94%),and 1 case(1.47%).Conclusion The application of percutaneous coronary intervention in patients with coronary artery disease has good performance in terms of clinical efficacy and prognostic recovery,resulting in the relief of patients'negative emotions and improvement of cardiac function indexes,and is of high clinical application value.
作者
张丽丽
ZHANG Li-li(Department of Cardiology,Zaozhuang Hospital of Zaozhuang Mining Group,Zaozhuang 277100,China)
出处
《中国实用医药》
2022年第19期71-73,共3页
China Practical Medicine
关键词
冠状动脉粥样硬化性心脏病
经皮冠状动脉介入
预后恢复
Coronary atherosclerotic heart disease
Percutaneous coronary intervention
Prognosis and recovery